Latest Funding And Investment News

Nova Minerals has secured US$43.4 million in non-dilutive funding from the U.S. Department of War to fully fund its domestic antimony supply chain development in Alaska, while also progressing its vast Estelle gold project with promising drilling results.

DigitalX Limited reports a stable Bitcoin treasury position and a modest cash decline in December 2025, alongside a positive return from its Lime Street Capital investment.

29Metals Limited has announced a fully underwritten $150 million entitlement offer to bolster liquidity, address operational disruptions at Golden Grove, and accelerate development projects including the Gossan Valley and Capricorn Copper restart.

Montaka Global Fund – Active ETF (ASX – MOGL) has announced a distribution of 10.80 cents per unit for the quarter ending 31 December 2025, alongside details of its Distribution Reinvestment Plan and tax status.

St Barbara has received a significant A$32 million deposit from Lingbao Gold Group, marking a key milestone in their strategic partnership to co-own the Simberi Gold Project. This deposit moves the companies closer to finalising a transformative A$370 million investment.

Magellan Investment Partners has launched the Magellan Global Opportunities Fund, an actively managed ETF targeting long-term outperformance of the MSCI World Index with a strong ESG focus and reduced management fees.

Magellan Investment Partners has launched the Magellan Global Equities Fund (Currency Hedged), an actively managed ETF listed on the ASX under ticker MHG, targeting a 9% annual return with integrated ESG considerations.

Magellan Investment Partners has launched the Magellan Global Fund - Open Class Units (MGOC), an actively managed global equity ETF aiming for 9% annual returns net of fees, integrating ESG principles and offering flexible trading options.

Magellan Investment Partners has launched the Airlie Australian Share Fund - Active ETF (AASF), offering investors a concentrated, actively managed portfolio of Australian equities with integrated ESG considerations. The fund combines liquidity via direct applications and Securities Exchange trading, targeting long-term capital growth and income.

Fidante Partners Limited has issued a replacement Product Disclosure Statement for the Ardea Real Outcome Bond Complex ETF, reducing transaction costs while maintaining its core investment strategy and fee structure.

Fidante Partners has issued a replacement Product Disclosure Statement for the Alphinity Global Sustainable Equity Fund - Active ETF, refining ESG disclosures and noting a rise in transaction costs. The Fund’s core investment approach and fees remain steady.

InhaleRx has boosted its funding facility by $12.6 million to accelerate clinical trials of SRX-25, a novel oral treatment for Treatment-Resistant Depression. This brings total available capital to $52.3 million, positioning the company for pivotal Phase III studies.